Supplemental Figure 1 from A Phase I Study of Veliparib (ABT-888) in Combination with Low-Dose Fractionated Whole Abdominal Radiation Therapy in Patients with Advanced Solid Malignancies and Peritoneal Carcinomatosis
Year: 2023
Type: supplementary-materials
Abstract: CTC number and ɣ-H2AX-positive CTC changes during treatment with radiotherapy and veliparib.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361884240
